Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00217646
Status:
COMPLETED
Last Update Posted:
2015-04-28
First Post:
2005-09-20
Brief Title:
Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia Myelodysplastic Syndromes or Blastic Phase Chronic Myelogenous Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adult Acute Basophilic Leukemia |
| Adult Acute Eosinophilic Leukemia |
| Adult Acute Megakaryoblastic Leukemia |
| Adult Acute Monoblastic Leukemia |
| Adult Acute Monocytic Leukemia |
| Adult Acute Myeloid Leukemia With Inv16p131q22 CBFB-MYH11 |
| Adult Acute Myeloid Leukemia With Maturation |
| Adult Acute Myeloid Leukemia With Minimal Differentiation |
| Adult Acute Myeloid Leukemia With t1616p131q22 CBFB-MYH11 |
| Adult Acute Myeloid Leukemia With t821q22q22 RUNX1-RUNX1T1 |
| Adult Acute Myeloid Leukemia With t911p22q23 MLLT3-MLL |
| Adult Acute Myeloid Leukemia Without Maturation |
| Adult Acute Myelomonocytic Leukemia |
| Adult Acute Promyelocytic Leukemia With t1517q22q12 PML-RARA |
| Adult Erythroleukemia |
| Adult Pure Erythroid Leukemia |
| Alkylating Agent-Related Acute Myeloid Leukemia |
| Blastic Phase |
| de Novo Myelodysplastic Syndrome |
| Previously Treated Myelodysplastic Syndrome |
| Recurrent Adult Acute Lymphoblastic Leukemia |
| Recurrent Adult Acute Myeloid Leukemia |
| Secondary Acute Myeloid Leukemia |
| Secondary Myelodysplastic Syndrome |
Keywords: